Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

2.

Identification of TOSO/FAIM3 as an Fc receptor for IgM.

Shima H, Takatsu H, Fukuda S, Ohmae M, Hase K, Kubagawa H, Wang JY, Ohno H.

Int Immunol. 2010 Mar;22(3):149-56. doi: 10.1093/intimm/dxp121. Epub 2009 Dec 30.

PMID:
20042454
3.

Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang DW, Gartland GL, Bertoli LF, Mori H, Takatsu H, Kitamura T, Ohno H, Wang JY.

J Exp Med. 2009 Nov 23;206(12):2779-93. doi: 10.1084/jem.20091107. Epub 2009 Oct 26.

4.

Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Li FJ, Kubagawa Y, McCollum MK, Wilson L, Motohashi T, Bertoli LF, Barton JC, Barnes S, Davis RS, Kubagawa H.

Blood. 2011 Nov 3;118(18):4902-9. doi: 10.1182/blood-2011-04-350793. Epub 2011 Sep 9.

5.

Harnessing the fcμ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia.

Vire B, Skarzynski M, Thomas JD, Nelson CG, David A, Aue G, Burke TR Jr, Rader C, Wiestner A.

Cancer Res. 2014 Dec 15;74(24):7510-7520. doi: 10.1158/0008-5472.CAN-14-2030. Epub 2014 Oct 24.

6.

Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses.

Ouchida R, Mori H, Hase K, Takatsu H, Kurosaki T, Tokuhisa T, Ohno H, Wang JY.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2699-706. doi: 10.1073/pnas.1210706109. Epub 2012 Sep 17.

7.

Unique ligand-binding property of the human IgM Fc receptor.

Honjo K, Kubagawa Y, Kearney JF, Kubagawa H.

J Immunol. 2015 Feb 15;194(4):1975-82. doi: 10.4049/jimmunol.1401866. Epub 2015 Jan 19.

8.

Monoclonal antibodies specific for human IgM Fc receptor inhibit ligand-binding activity.

Kubagawa Y, Honjo K, Kang DW, Kubagawa H.

Monoclon Antib Immunodiagn Immunother. 2014 Dec;33(6):393-400. doi: 10.1089/mab.2014.0053.

9.

FcμR interacts and cooperates with the B cell receptor To promote B cell survival.

Ouchida R, Lu Q, Liu J, Li Y, Chu Y, Tsubata T, Wang JY.

J Immunol. 2015 Apr 1;194(7):3096-101. doi: 10.4049/jimmunol.1402352. Epub 2015 Mar 2.

10.

The IgM receptor FcμR limits tonic BCR signaling by regulating expression of the IgM BCR.

Nguyen TT, Kläsener K, Zürn C, Castillo PA, Brust-Mascher I, Imai DM, Bevins CL, Reardon C, Reth M, Baumgarth N.

Nat Immunol. 2017 Mar;18(3):321-333. doi: 10.1038/ni.3677. Epub 2017 Jan 30.

PMID:
28135254
11.

FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Gupta S, Agrawal S, Gollapudi S, Kubagawa H.

Hum Immunol. 2016 Dec;77(12):1194-1201. doi: 10.1016/j.humimm.2016.10.003. Epub 2016 Oct 14.

PMID:
27751883
12.

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG.

Blood. 2005 Jun 15;105(12):4820-7. Epub 2005 Feb 22.

13.

IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.

Weston KM, Tangye SG, Dunn RD, Smith A, Morris MB, Raison RL.

J Mol Recognit. 2001 Jul-Aug;14(4):245-53.

PMID:
11500971
14.

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.

Pallasch CP, Schulz A, Kutsch N, Schwamb J, Hagist S, Kashkar H, Ultsch A, Wickenhauser C, Hallek M, Wendtner CM.

Blood. 2008 Nov 15;112(10):4213-9. doi: 10.1182/blood-2008-05-157255. Epub 2008 Aug 15.

15.

The long elusive IgM Fc receptor, FcμR.

Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang DW, Jones D, Nishida N, Miyawaki T, Bertoli LF, Sanders SK, Honjo K.

J Clin Immunol. 2014 Jul;34 Suppl 1:S35-45. doi: 10.1007/s10875-014-0022-7. Epub 2014 May 3. Review.

16.

The old but new IgM Fc receptor (FcμR).

Kubagawa H, Kubagawa Y, Jones D, Nasti TH, Walter MR, Honjo K.

Curr Top Microbiol Immunol. 2014;382:3-28. doi: 10.1007/978-3-319-07911-0_1. Review.

PMID:
25116093
17.
18.

Complement-activating IgM enhances the humoral but not the T cell immune response in mice.

Ding Z, Bergman A, Rutemark C, Ouchida R, Ohno H, Wang JY, Heyman B.

PLoS One. 2013 Nov 8;8(11):e81299. doi: 10.1371/journal.pone.0081299. eCollection 2013.

19.

Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.

Rozková D, Novotná L, Pytlík R, Hochová I, Kozák T, Bartůnková J, Spísek R.

Int J Cancer. 2010 Mar 1;126(5):1132-43. doi: 10.1002/ijc.24832.

20.

Cross-linking of membrane IgM on B CLL cells.

Grillot-Courvalin C, Hivroz C, Brouet JC.

Nouv Rev Fr Hematol. 1988;30(5-6):301-4.

PMID:
3146745

Supplemental Content

Support Center